(Received for publication, August 5, 1996, and in revised form, October 25, 1996)
From the Unité de Recherches Hormones et Reproduction, INSERM, Unité 135, Hôpital de Bicêtre, 94275 Le Kremlin Bicêtre, France
The thyrotropin (TSH) and follicle-stimulating
hormone (FSH) receptors are present mainly on the basolateral cell
surface in the thyroid gland and in Sertoli cells, whereas in ovarian and in testicular cells, the luteinizing hormone (LH) receptors are
distributed throughout the cell surface. When expressed in Madin-Darby
canine kidney (MDCK) cells, all three receptors accumulated at the
basolateral cell surface showing that they carry the corresponding targeting signals. The receptors were directly delivered to the basolateral surface of the MDCK cells. A minor fraction of the gonadotropin receptors but not of TSH receptors was secondarily targeted to the apical surface through transcytosis. The mechanisms of
basolateral targeting and transcytosis were analyzed using the FSH
receptor as a model. Both were insensitive to brefeldin A and pertussis
toxin. Gs activation by
AlF4 and cholera toxin provoked
a marked enhancement of FSH receptor transcytosis. The population of
Gs proteins involved in this mechanism was different from
that involved in signal transduction since neither FSH nor forskolin
mimicked the effects of AlF4
and cholera toxin. Gs activation provoked a similar
effect on LH receptor distribution in MDCK cells, whereas it did not
modify the compartmentalization of the TSH receptor. Hormone-specific transcytosis was observed in MDCK cells expressing the gonadotropin (FSH and LH) receptors and was increased after cholera toxin
administration.
The gonadotropin (LH1 and FSH) and thyrotropin (TSH) receptors belong to the large family of G-protein-coupled receptors (1-4). They possess the distinctive seven transmembrane spanning domains. However, they form a specific subgroup characterized by the presence of a large extracellular domain constituted by the repetition of leucine-rich motif (5). This ectodomain is responsible for the high affinity hormone binding (6-9). Gonadotropin and TSH receptors are mainly coupled to Gs and thus activate adenylate cyclase. The same receptors are also able to activate phospholipase C at high hormone concentrations. Mutations of the receptors have been described leading either to their constitutive activation (10-12) or in contrast to a loss of receptor function (13-15).
Little is known about the cellular trafficking of G-protein-coupled receptors in general and of this subgroup of receptors in particular. Ultrastructural immunocytochemistry has been used to analyze the internalization mechanisms of some receptors (16-18). LH receptor-driven hormone transcytosis was observed through endothelial cells of testicular blood vessels (19). Recently immunocytochemistry using specific monoclonal antibodies demonstrated the basolateral distribution of the TSH receptor in thyroid cells (20) and of the FSH receptor in Sertoli cells (21), whereas the LH receptor was present all over the cell surface of thecal, granulosa, and luteal cells in the ovary and Leydig cells in the testes (22, 23).
The question was thus raised as to whether these differences in cellular distribution were due to differences in the structure of receptors or simply secondary to the fact that thyroid follicular cells and Sertoli cells are polarized, whereas the LH receptor-expressing cells are not polarized. Another question raised was whether the mechanisms of receptor basolateral delivery were cell-specific or whether the receptors contained specific signals that could direct them to this membrane compartment in any polarized cell. To answer these questions we have established MDCK cell lines that express the FSH, LH, and TSH receptors. Using these models we have analyzed the distribution of the receptors in polarized monolayers.
MDCK cells (type II) were seeded and grown on coverslips (Nunc) or filters (0.4-µm polycarbonate, tissue culture-treated, Transwell costar) as described previously (24, 25).
Antireceptor AntibodiesMouse monoclonal antibodies FSHR323 (21), LHR38 (26), and T5-51 or T5-317 (20, 27) recognize an epitope in the extracellular domain of the FSH, LH, and TSH receptors, respectively. Antibody T3-365 has been raised against the intracellular domain of the TSH receptor (20). The rabbit polyclonal TSHR-19-389 antibody raised against the extracellular domain of the TSH receptor was also used in some experiments.
Establishment of MDCK Cell Lines Permanently Expressing FSH, LH, and TSH ReceptorsMDCK cell lines were obtained and maintained as described (28, 29) after cotransfection with expression vectors encoding either hFSHR (pSG5-hFSHR) (21), hTSHR (pSG5-hTSHR) (30), or pLHR (pCMV-LHRA) (8) and with the plasmid pSV-Neo which confers resistance to the antibiotic G418 (31). These clones were screened for receptor expression by immunocytochemistry using monoclonal anti-receptor antibodies. Sodium butyrate (10 mM) (Sigma) was used to increase the expression of the transfected genes as described (32). At least two different clones were studied for each receptor.
Verification of the Polarized Phenotype of Transfected MDCK CellsThe transepithelial resistance of the clones was ~300 ohms/cm2. Indirect immunofluorescence studies were performed as described (33) using antibodies (a gift of A. Le Bivic) directed against a basolateral (BC11) or an apical (BB18) endogenous proteins of MDCK cells. Polarized apical secretion of an endogenous glycoprotein complex (25) was verified as described previously (34).
Purification and Western Blot Analysis of the Gonadotropin and TSH Receptors Expressed in MDCK CellsThese procedures were performed as described previously (20, 21, 26, 30).
Metabolic Labeling and Immunopurification of the Human FSH Receptor Expressed in MDCK CellsAfter 2 days of growth, metabolic labeling of MDCK cells expressing the human FSH receptor was performed as described previously (21). The FSH receptor was immunopurified as described (21).
ImmunofluorescenceIndirect immunofluorescence was performed on MDCK cells grown to confluence on coverslips (33). The cells were washed with PBS+ (phosphate-buffered saline, Dulbecco's formulation with 0.1 mM CaCl2 and 1 mM MgCl2) and fixed for 15 min in 3% paraformaldehyde in PBS+. After washing, the aldehyde groups were quenched with 50 mM NH4Cl in PBS+ for 30 min. After 1 h saturation with PBS+, 1% BSA (albumin, fraction V, Boehringer Mannheim) cells were incubated for 2 h at room temperature in a humid chamber with the monoclonal antireceptor antibodies (FSHR323, LHR38, or T5-317 for the clones expressing FSH, LH, and TSH receptors, respectively) (10 µg/ml in PBS+, 1% BSA). The cells were then washed with PBS+, 1% BSA, 0.1% Tween 20 (Sigma) and incubated for 1 h with a fluorescein isothiocyanate (DAKO) or a Cy3-labeled rabbit anti-mouse IgG (Sigma). After washing, the cells were mounted with Citifluor (Agar). The cells were observed with a Leitz microscope or with a Zeiss microscope (Axiovert 135M) in conjunction with a confocal laser scanning unit (Zeiss LSM 410). To open the tight junctions, MDCK cells were incubated for 1 h with Ca2+-free Dulbecco's modified Eagle's medium, washed twice with calcium and magnesium-free PBS, and then incubated for various periods with 5 mM EGTA in the same buffer. The cells were then fixed in 3% paraformaldehyde for 15 min and further processed as described above.
cAMP AssaycAMP assay was performed as described (21, 26, 35). Cell stimulation was achieved with 50 nM hCG (Organon), 50 nM FSH (Serono), or 1 mUI/ml TSH (bovine TSH, UCB).
Surface Immunoprecipitation of FSH, LH, and TSH Receptors Expressed in MDCK CellsPolarized monolayers of cells grown on 24-mm filters were studied after 2, 3, or 4 days of culture. The optimal receptor detection was obtained with the 2-day culture. Cells were pulse-labeled for 1 h as described (21) with 1 mCi/ml Expre35S35S (DuPont NEN) and chased for 3 h in the same medium containing unlabeled amino acids and 1% BSA. Surface immunoprecipitation was performed as described (36) using monoclonal antibodies FSHR323 or LHR38 (30 µg/ml) or polyclonal antibody TSHR 19-389 (dilution 1/300) added in the apical or in the basolateral compartment during the chase period. Extraction and purification of receptor-antibody complex were performed as described (30, 36). All experiments were performed at least twice with triplicate samples.
Treatment of Cells with Drugs and ToxinsBrefeldin A
(Sigma) (0-20 ng/ml) was added to the cells (37)
during the pulse and the chase periods. For pertussis toxin (Sigma) treatment, two conditions were used which
yielded the same results, either 200 ng/ml before (16 h) and throughout
the experiment (38) or 1 µg/ml toxin throughout the experiment (39). For cholera toxin (Sigma) treatment, two conditions
were also tested which yielded the same results, 10 µg/ml toxin
during the pulse (39, 40) or 2 µg/ml before (3 h) and throughout the experiment (41). AlF4 was prepared as
described (42) and added during the first hour of chase. Forskolin
(Sigma) (1 µM) was used during the
incubation at 37 °C associated with 500 µM
3-isobutyl-1-methylxanthine (Sigma) (40).
SDS-PAGE was performed as described (20, 30). The gels were fixed and processed for fluorography. Quantification was performed using densitometric scanning.
Protease Sensitivity ExperimentsPolarized monolayers of MDCK cells expressing FSHR, LHR, and TSHR were grown on filters and pulse-labeled as described above. Trypsin (Life Technologies, Inc.) (50 µg/ml) was added to the apical or to the basolateral medium during the chase period, whereas a 6-fold excess of soybean trypsin inhibitor (Boehringer Mannheim) was added in the opposite compartment (32).
Hormone Transcytosis AssayCells were cultured on filters for 48 h. The filters were then placed on 30-µl drops containing radioactive ligands (125I-FSH (DuPont NEN), (130 µCi/µg, 26 µCi/ml), 125I-hCG, (DuPont NEN) (90 µCi/µg, 86 µCi/ml), or 125I-bTSH (70 µCi/µg; 3 µCi/ml) (ERIA Diagnostic Pasteur)) in the absence or in the presence of an excess of unlabeled ligand for 10 min at 37 °C. After extensive washing at 4 °C, the filters were then transferred to a 12-well culture plate and fresh PBS, 1% BSA (200 µl) was added to both the apical and the basolateral chambers (41). The apical medium was replaced after 30, 60, and 90 min, and the radioactivity present in all fractions was counted. Saturable transfer of the hormone was determined in the presence of an excess of unlabeled hormone. The cumulative appearance of the labeled ligand in the apical medium (hormone transcytosis) was determined. In some experiments cells were incubated at 37 °C with 10 µg/ml cholera toxin for 1 h before the incubation with the hormone. The total radioactivity initially bound to the basolateral cell surface was determined in parallel by acidic treatment of cells for 3 min with PBS, 50 mM glycine, pH 2, 1% BSA. The internalized fraction of the hormone corresponded to the radioactivity remaining on the filter after the acidic wash. All the fractions were then precipitated with 10% trichloroacetic acid and counted in a gamma counter.
MDCK cells were transfected with expression vectors
encoding the receptors and a gene imparting resistance to neomycin.
Among neomycin-resistant clones, those giving the strongest
immunocytochemical reaction with anti-TSH, anti-FSH, and
anti-LH receptor monoclonal antibodies were selected. It was necessary
to verify that these cells lines have conserved their ability to become
polarized when grown to confluency. Three methods were used. 1) The
transepithelial resistance was measured in all clones expressing TSH,
FSH, and LH receptors; it was 300 ohms/cm2 as has
previously been observed for MDCK cells (43, 44). 2) The monoclonal
antibody BC11 recognizes an antigen that has been shown to be
restricted to the basolateral compartment of MDCK cells (a gift of A. Le Bivic). The cell lines expressing the receptors were thus incubated
through their apical side with the antibody either after treatment with
EGTA or in the absence of such a treatment (33). No immunofluorescence
could be observed in the latter case, whereas EGTA treatment that opens
the tight junctions and thus allows antibody contact with the
basolateral domain provoked a strong immunofluorescence signal with a
characteristic reticular pattern (see below). Confocal microscopy
confirmed that the labeling indeed corresponded to the basolateral
domain of the cells (not shown). 3) Predominant apical secretion of the 80-kDa protein (gp80 marker) was observed in control and transfected MDCK cells (not shown) (25).
It was also necessary to verify that these cell lines were expressing
functionally active receptors of normal structure. In all cases, the
receptors were enriched by immunopurification and then analyzed by
Western blotting using specific monoclonal antibodies. In cells
expressing FSH receptors two species were detected (Fig. 1) of apparent molecular mass 87 and 81 kDa. Treatment
with peptide N-glycanase F (21) which removes all
carbohydrate chains resolved both of them into a 75-kDa holoprotein.
Incubation with endoglycosidase H (21) (which cleaves only mannose-rich
precursor carbohydrates) resulted in the transformation of the 81-kDa
species into the 75-kDa protein, whereas the 87-kDa receptor was
unchanged. These experiments thus suggested that the 87-kDa species
corresponds to the receptor with mature complex carbohydrates, whereas
the 81-kDa species is the precursor glycoprotein carrying mannose-rich carbohydrate residues.
To confirm this conclusion pulse-chase experiments were performed.
After 1 h of labeling with radioactive amino acids followed by
immunoprecipitation with antireceptor antibodies, only the 81-kDa
protein was observed (Fig. 2). After 90 min of chase,
the 87-kDa receptor became apparent and its concentration increased for
longer chase periods, whereas the concentration of the 81-kDa protein
decreased. These observations thus confirmed that the 81-kDa species
was a precursor of the 87-kDa mature FSH receptor. Similar observations
have been previously made in human ovaries and transfected L cells
(21). Western blot experiments were also performed for LH and TSH
receptors expressed in MDCK cells. In the case of the LH receptor (Fig.
1) two species were also observed at ~89 and 68 kDa. Endoglycosidase
digestions showed that the former corresponds to the mature receptor,
whereas the latter corresponds to the previously described mannose-rich
precursor of the LH/CG receptor (8) (data not shown). In the case of the TSH receptor antibodies raised against the extracellular domain detected three protein species (Fig. 1): one at ~120, one at ~90, and one at ~60 kDa. Similar molecular species have been previously described for the TSH receptor expressed in L cells (30); the largest
species corresponds to the mature uncleaved receptor, the 90-kDa
species to the mannose-rich precursor, whereas the 60-kDa protein
corresponds to the subunit of the cleaved mature receptor.
Antibodies raised against the intracellular domain of the receptor
detected the two larger precursor species and also the 35-45-kDa
subunit of the cleaved mature receptor (not shown). In human thyroid
cells, only cleaved mature receptor is present (traces of the
mannose-rich precursor may be detected, however) (20, 30). Thus, in
transfected MDCK cells, as well as in transfected L cells, the TSH
receptor undergoes incomplete maturation and incomplete cleavage.
Basolateral Localization of a Major Fraction of FSH, TSH, and LH Receptors in MCDK Cells
Cells grown on coverslips were incubated
on their apical surface with antireceptor antibodies. As shown in Fig.
3, FSH, TSH, and LH receptors could not be immunostained
in these conditions. However, when the cells were treated with EGTA,
opening the tight junctions and thus allowing the antibodies to reach
the basolateral surface, immunostaining of the three receptors in the
corresponding cells could be observed. The labeling decorated the
cellular contours. As stated above, correct polarization of the
confluent monolayers was verified with antibody BC11 directed against a
basolateral endogenous antigen (Fig. 3). Antibody BB18 recognizing an
apical endogenous antigen of MDCK cells was also used as control. A
strong staining was obtained with this antibody in MDCK cells in the absence of EGTA treatment (not shown). For cells transfected with each
receptor, analysis of immunofluorescence by confocal microscopy in
EGTA-treated cells was performed. Fig. 4 shows the LH
receptor distribution. Serial XY horizontal optical sections
were performed from the apical to the basal membrane of transfected
MDCK cells. Antibody BB18 (Fig. 4C, a-d)
strongly stained the sections corresponding to the apical surface,
whereas antibody BC11 (Fig. 4A, a-d) and the monoclonal
antireceptor antibody (Fig. 4B, a-d) stained sections corresponding to the basolateral surface. The same conclusions were
derived from XZ vertical sections (Fig. 4,
f).
Immunocytochemistry or immunofluorescence do not yield quantitative
data. Such data can be obtained by metabolic labeling of the receptor
followed by either domain-selective biotinylation of the receptor (45)
or surface immunoprecipitation (36). Both techniques can be applied
separately to the basolateral and apical compartments yielding
quantitative measurements of receptors present on each surface.
However, gonadotropin and TSH receptors are extremely "sticky"
molecules that tend to aggregate. The biotinylation method thus led to
the nonspecific precipitation of a major fraction of the intracellular
mannose-rich receptor precursor (not shown). This problem still existed
but was markedly reduced with the surface immunoprecipitation method.
The latter was thus used for all further experiments. MCDK cells
expressing FSHR, TSHR, or LHR were pulse-labeled with radioactive amino
acids for 1 h (see "Materials and Methods"). Antireceptor
antibodies were added either to the basal or to the apical compartments
during the 3-h chase period. The receptor-antibody complexes were
purified and analyzed by gel electrophoresis (Fig. 5).
For FSHR and LHR ~85% of the receptor molecules were localized on
the basolateral surface. In the case of the TSHR (which has not yet
undergone cleavage after 3 h of chase (30)), the totality of the
receptor molecules was found on the basolateral surface, no radioactive
receptor being detected on the apical surface.
It has been previously observed that the distribution of some proteins
may not parallel the distribution observed when studying their
biological activity (46). We thus incubated polarized MDCK cells
expressing the various receptors with the respective hormones applied
either to the apical or to the basolateral compartments. Measurement of
cAMP accumulation (Fig. 6) confirmed that the majority of active LH and FSH receptor molecules were present on the basolateral surface, whereas only minimal cAMP production was observed when the
hormone was applied to the apical compartment. In the case of MDCK
cells expressing TSH receptor, hormone-induced cAMP accumulation could
only be observed in the basolateral compartment.
Targeting Pathways of FSH, LH, and TSH Receptors to Basolateral and Apical Membranes
Various pathways have been described for the polarized distribution of membrane proteins in epithelial cells (reviewed in Refs. 47, 48). After their synthesis, the proteins may be directly delivered to the basolateral or the apical surface; they may be delivered to one of these surfaces and then may undergo a transcytosis to the opposite surface (49), or they may be randomly delivered to both surfaces but thereafter stabilized in one of the compartments by interaction with some specific component of this compartment (50). To distinguish between these various possibilities, we followed the kinetics of appearance of the newly synthesized FSH receptor on the basolateral and apical cell surfaces. This was performed by metabolic labeling of the cells followed by selective surface immunoprecipitation at various time intervals.
As shown in Fig. 7, FSH receptor was initially detected
on the basolateral surface thus suggesting a direct sorting to that compartment. The apical receptor was observed only at later chase times. These results implied that transcytosis from the basolateral compartment may be responsible for the low amount of receptor present
on the apical cell surface. To further test this hypothesis, we used
surface trypsin digestion. Cells were incubated with trypsin either in
the apical or basolateral compartments, and the result of this
treatment on receptor delivery to the opposite compartment was
examined. When trypsin was applied to the apical compartment, the
apical receptor disappeared, but there was no change in the concentration of the basolateral receptor. On the contrary when trypsin
was applied to the basolateral compartment both the basolateral and the
apical receptors disappeared (Fig. 8). These
observations demonstrated a direct basolateral targeting of receptor
followed by a limited transcytosis toward the apical surface.
Identical experiments were performed with MDCK cells expressing LH receptors with similar results (Fig. 8). In the case of TSH-expressing MDCK cells, addition of trypsin to the apical compartment did not change the concentration of basolateral receptor, confirming the direct basolateral targeting of the protein. However, apical immunoprecipitation in the absence of trypsin failed to detect any receptor molecules, and thus no transcytosis occurred (Fig. 8).
Effect of Brefeldin A and Effectors of Trimeric G Proteins on Receptor PolarizationThe transport mechanisms of various proteins have been shown to be differentially affected by brefeldin A (37, 51, 52). It has been proposed that these differences were due to the existence of different populations of transport vesicles (53) or, alternatively, to the existence of several specific components which insert different proteins into specifically targeted vesicles (52). Brefeldin A could thus exert different effects on the sorting of specific proteins either by acting on a subset of the vesicles (54) or, alternatively, by inhibiting the insertion into a given subset of vesicles of only a fraction of proteins. It has also been proposed that trimeric G-proteins play an important role in cell surface compartmentalization, Gs being involved in apical transport whereas Gi was thought to be involved in basolateral targeting (41, 55, 56). To examine these mechanisms in the case of FSH receptors, the following experiments were performed.
MDCK cells expressing FSH receptor were incubated with increasing
concentrations of brefeldin A (5-20 ng/ml) as described by Low
et al. (37). It was verified that at all these
concentrations, the drug did not open the tight junctions. Brefeldin A
did decrease slightly the transepithelial resistance, as described
previously (57), but the resistance was never lower than 150 ohms/cm2. The concentration of FSH receptor at the
basolateral and at the apical surface was unchanged by brefeldin A at
various concentrations (see Fig. 9 for the effect of
brefeldin A at 20 ng/ml).
Administration of pertussis toxin, which inactivates the
Gi subunits, had no effect on receptor concentration at
either the basolateral or the apical surface of the cells (Fig. 9).
Thus, basolateral targeting of FSH receptor does not seem to be
dependent on Gi.
We then tested the activity of aluminum fluoride
(AlF4) which is known to activate the
various heterotrimeric G-proteins. As shown in Fig. 9, this compound
markedly increased the proportion of apical receptor whose
concentration became equivalent to that of the basolateral receptor.
Given the lack of modification of Gi, this result suggested
a possible involvement of Gs in receptor targeting. We thus
incubated the FSHR-expressing cells with cholera toxin, which activates
G
s. This treatment also provoked a major modification of
the distribution of the receptor, with a significant increase in the
concentration of the apical receptor (Fig. 9). Such an effect of both
AlF4
and of cholera toxin could have
been due to a reorientation of the initial targeting pathway of the
receptor, the receptor being inserted in vesicles targeted to both
apical and basolateral compartments. An alternative mechanism would
involve an increased transcytosis of receptor after initial delivery to
the basolateral surface. To distinguish between these two
possibilities, we added trypsin to the basolateral compartment of
cholera toxin-treated cells. If there was a direct targeting of the
receptor to the apical compartment, the concentration of the apical
receptor should not have been modified by trypsin treatment. On the
contrary, in the case of increased transcytosis, the apical receptor
should have disappeared since its proteolysis would have occurred
during its residency on the basolateral cell surface. As shown in Fig.
9, the latter result was observed, clearly suggesting that
Gs activation leads to an enhanced transcytosis of the FSH
receptor from the basolateral to the apical membrane.
Besides modifying the apical/basolateral ratio of receptor, both
AlF4 and cholera toxin increased the
total concentration of receptor observed on the cell surface. A
metabolic labeling experiment was performed on untreated cells and on
cells treated by cholera toxin. This treatment did not change the rate
of synthesis of the receptor (data not shown). Thus Gs
activation may modify the turn-over rate of the receptor, possibly by
diverting some of the internalized receptor from the lysozymal
degradation pathway (17) to the transcytotic pathway.
Since the FSH receptor is coupled to Gs and as this
coupling leads to activation of adenylate cyclase, it could be imagined that activation of the receptor by the hormone and the ensuing increase
in cAMP concentration were responsible for receptor redistribution. To
examine this hypothesis, MDCK cells expressing the FSH receptor were
treated either with FSH or with forskolin (Fig. 9). These treatments
did not change the pattern of polarization of the FSH receptor. There
was no increase in the concentration of the apical receptor, as
compared with that observed after incubation with cholera toxin or
AlF4. These results suggested that the
pool of Gs molecules involved in receptor transcytosis is
different from the pool of Gs molecules which is coupled to
the FSH receptor at the plasma membrane. They also implied that the
effect of Gs is direct or at least that it involves a
downstream effector which is different from adenylate cyclase.
Given that FSH receptor polarization was modified by the activation of
Gs, we examined whether similar effects could be observed for LH and TSH receptors. To this end, MDCK cells expressing LH or TSH
receptors were incubated with cholera toxin. The distribution of LH
receptors (Fig. 10) was changed in a manner very
similar to that observed for FSH receptors, with cholera toxin
treatment provoking an important increase in apical receptor
concentration. This increase was due to an increased transcytosis since
trypsin digestion of basolateral proteins prevented enhancement of
apical receptor concentration. Conversely, cholera toxin had no effect on TSH receptor polarization (Fig. 10).
Hormone Transcytosis through MDCK Cells Expressing Gonadotropin and TSH Receptors
We have observed a limited degree of receptor
transcytosis from the basolateral to the apical compartments in FSHR-
and LHR-expressing MDCK cells. This transcytosis was markedly increased
when Gs was activated by cholera toxin. We thus wondered
whether receptor transcytosis could be accompanied by hormone
transcytosis. Cells were thus incubated on their basolateral surface
with either 125I-FSH, 125I-hCG, or
125I-TSH, and hormone appearance on the apical side was
monitored (Fig. 11). Only trichloroacetic
acid-precipitable radioactivity was considered to be significant since
125I originating from proteolyzed, degraded hormone appears
in part in the apical compartment. Furthermore, only saturable
(suppressed by excess unlabeled hormone) receptor-mediated transcytosis
was taken into account. A minimal level of transcytosis was observed in
untreated FSH and LH receptor-expressing cells. This transcytosis was
markedly increased by cholera toxin treatment. When control MDCK cells
were used (LH receptor-expressing cells incubated with 125I-FSH and FSH receptor-expressing cells incubated with
125I-hCG), no hormone transcytosis could be detected. In
the case of TSH receptor-expressing MDCK cells, no transcytosis could
be observed either in the absence or in the presence of cholera toxin (Fig. 11).
Expression of gonadotropin and thyrotropin receptors in MDCK cells did not yield high amounts of mature proteins on the surface of the cells. Indeed the biosynthetic machinery of MDCK cells does not process these proteins very efficiently, and for all three receptors there is accumulation inside the cells of mannose-rich precursor glycoproteins (8, 21, 30). However the choice of MDCK cells for this study was justified by their efficient polarization and the large amount of information available about the cellular trafficking of various polarized surface proteins in these cells (24, 43, 58).
The physiological basolateral localization of FSH (21) and TSH (20) receptors in Sertoli cells and thyrocytes was reproduced in the heterologous MDCK cells. This suggested that the corresponding targeting signals are embodied in the proteins themselves and are functional in heterologous polarized cells. Furthermore, the basolateral localization of the LH receptor in MDCK cells, a receptor which is not physiologically polarized (22, 23), suggested that the LHR also possessed a basolateral targeting signal as the other members of this receptor subgroup. In vitro mutagenesis will allow us to identify the signals involved in all three receptors.
A basolateral localization has been previously observed for two other
G-protein-coupled receptors, the 2A-adrenergic receptor in MDCK cells (38) and the parathyroid hormone receptor in epithelial kidney cells (59, 60, 61). Conversely, the adenosine A1 receptor is localized essentially on the apical surface of MDCK cells
(62). The basolateral targeting of proteins in epithelial cells may
occur via different mechanisms (see above). Indeed, different
mechanisms may be used for closely related proteins; the
2A- and
2C-adrenergic receptors are
delivered directly to the basolateral surface of MDCK cells, whereas
the
2B adrenergic receptor is inserted randomly into
both cell surface domains but is retained preferentially on the
basolateral surface (its half-life being shorter on the apical surface
(63)). In the case of the FSH receptor, both time course studies of
receptor appearance on the cell surface and protease digestion
experiments showed a direct basolateral targeting.
A small proportion (10-15%) of the gonadotropin FSH and LH receptors are localized on the apical surface of MDCK cells. In these cells, previous studies involving a number of proteins have shown that apical localization in most cases results from direct targeting (64). This does not seem to be the case for gonadotropin receptors that are delivered to the basolateral surface and secondarily undergo transcytosis to the apical surface.
Brefeldin A inhibits the basolateral localization of the low density lipoprotein receptor (65) and of the polymeric immunoglobulin receptor (52), whereas it is without effect on the polarization of various other proteins (37, 66) including the FSH receptor. Two hypotheses have been proposed to explain these differences: either different carrier vesicles may be used to reach the same compartment and brefeldin A might act by selectively blocking one of these pathways, or alternatively, the insertion of different proteins into a given set of vesicles is mediated by several mechanisms and brefeldin A may alter selectively only some of them.
Monomeric G-proteins, specially of the rab and ARF families, are
involved in practically all of the steps of vesicular trafficking (67,
68). The role of the heterotrimeric G-proteins has only recently been
studied. Several immunocytochemical studies revealed the presence of
heterotrimeric G-proteins in various intracellular compartments (69).
Stow et al. (70) initially showed a role for
Gi3 in the secretion of proteoglycan by LLC-PK1 cells.
Pimplikar and Simons (55) established that the apical and basolateral targeting of surface proteins was regulated in the trans-Golgi compartment by heterotrimeric G-proteins. These authors proposed a
general mechanism whereby Gi inhibited basolateral
transport whereas Gs stimulated apical transport.
Gs has also been implicated in the transcytosis of the
polymeric immunoglobulin receptor (41). These observations led to
discussions of hypothetical receptors or sorter proteins coupled to
these vesicular G-proteins and of possible regulatory mechanisms (69,
71). The G-proteins might regulate the formation of vesicles or might
facilitate the incorporation of the cargo molecules in the vesicles by
interacting with a coat protein (56). The FSH receptor does not follow
the model proposed by Pimplikar and Simons (55) since inhibition of
Gi was without effect on receptor distribution, whereas
stimulation of Gs did not increase direct receptor apical
transport but enhanced receptor transcytosis. This may be due to the
rerouting of internalized receptor from the degradative lysozymal
pathway toward the transcytotic pathway. Such a mechanism would explain
the increased concentration of total surface receptor without change in
receptor rate of synthesis.
The compartmentalization and surface targeting of the LH receptor closely resembled those of the FSH receptor in MDCK cells. For both receptors, a minimal transcytosis of receptor and hormone is observed which is increased by Gs activation. This phenomenon, which is very limited in MDCK cells, may be more important in other cell types. In endothelial cells of testicular vessels, receptor-mediated transcytosis of hormone has been described (19). This transcytosis allows the hormone to cross the endothelial barrier and to be concentrated at close contact of target cells. FSH has been observed in the rete testis fluid, perhaps resulting from a transcytosis through Sertoli cells (72).
The TSH receptor also displayed a basolateral localization in MDCK cells, but no transcytosis was observed, and there was no apparent effect of Gs activation. These differences between the gonadotropin and TSH receptor may be related to the existence of an interaction of the TSH receptor with a cellular or an extracellular component of MDCK cells. Interaction of Na+/K+-ATPase with the cytoskeleton has been shown to stabilize the protein at the basolateral surface (50). The possibility remains, however, that transcytosis may occur in other cell types (endothelial cells).
It will be interesting now to analyze the mechanisms of receptor targeting in transfected endothelial cells. Furthermore, in vitro mutagenesis should allow the definition of the signals involved in receptor targeting, transcytosis, and endocytosis of this subgroup of G-protein-coupled receptors.
We thank Drs. D. Louvard (Institut Pasteur, Paris, France) and A. Le Bivic (Centre National de la Recherche Scientifique, Marseille, France) for helpful discussions. We are grateful to V. Coquendeau, A. D. Dakhlia, and M. Nascimento for word processing. We thank P. Leclerc (Service commun de microscopie confocale, IFR21 "Hormones et Génétique") for his help in confocal microscopy analysis.